Effect of shIGFBP-3 Intracavernosal Injection on Erectile Function in Rats of Diabetes-Induced Erectile Dysfunction

彭谋,刘全亮,周章炎,杨中华,万少平,王行环
DOI: https://doi.org/10.14188/j.1671-8852.2012.05.018
2012-01-01
Abstract:Objective: To evaluate the effect of shIGFBP-3 intracavernosal injection in the treatment of diabetes-induced erectile dysfunction in rats, by observing the variety of intracavernous pressure (ICP) and the density of smooth muscle of the corpus cavernosum. Methods: Thirty Sprague Dawley rats were established models of diabetes-induced erectile dysfunction by streptozotocin (STZ) and were randomized into three groups. Each group was respectively injected into corpus cavernosum with pGPU6/GFP/Neo-shIGFBP-3, pGPU6/GFP/Neo-randomer shRNA, and normal saline as control. Three months later, intracavernous pressure was monitored to evaluate the function of erection in model rats and the variety of smooth muscle of the corpus cavernosum was observed. Western blot was adopted to determine the expression of IGFBP-3 protein in corpus cavernosum. Results: ICP in group of shIGFBP-3 was (112±16) mmHg, which was higher than (63±11) mmHg in randomer shRNA group and (59±12) mmHg in control group, and the difference was statistically significant (P<0.05). Density of smooth muscle in corpus cavernosum in shIGFBP-3 group was significantly increased as compared with that respectively in randomer shRNA group and control group. The expression of IGFBP-3 protein in shIGFBP-3 group decreased significantly by Western blot. Conclusion: shIGFBP-3 gene injection can increase intracavernous pressure and improve density of smooth muscle in corpus cavernosum of diabetes-induced erectile dysfunction rats.
What problem does this paper attempt to address?